The CDC said Thursday that the mutations, detected in a sample taken from a Louisiana patient, may help bind the virus to the ...

Here we are, on the cusp of the midway point in a decade that has been, in global health and infectious diseases terms, a lot ...

In STAT's "jealousy list" for 2024, STAT staffers explain what makes a selection of stories they read in other publications ...

STAT '3 to Watch' series looks at biotech industry issues in 2025: Trump administration uncertainties, pharma deals in China, ...

Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to ...

The killing of UnitedHealthcare CEO Brian Thompson has sparked extraordinary public interest in the nation’s health insurance industry. Much of the outcry has centered not on the killing itself ...

Retractions are meant to maintain trust in science — but on social media, they're often used to reinforce anti-science bias ...

The “skin in the game” experiment has failed to achieve its primary raison d’être. Over the past two decades, it has not ...

One of those experts was Stanley Biber, a pioneer of vaginoplasties in the U.S. and perhaps the country’s busiest ...

Bone marrow transplants, long a mainstay of blood cancer treatments, are becoming less common in favor of options like CAR-T ...

Reports that cows have been infected despite farmers' preventive measures indicate there are multiple routes of transmission ...

Although research and development funding for tuberculosis reached new heights last year, the total fell substantially short of goals set by the United Nations and most of the increase came from ...